97 results match your criteria: "Sands Constellation Heart Institute[Affiliation]"

Transcaval Versus Transaxillary TAVR in Contemporary Practice: A Propensity-Weighted Analysis.

JACC Cardiovasc Interv

May 2022

Emory Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: https://twitter.com/AdamGreenbaumMD.

Objectives: The aim of this study was to compare transcaval and transaxillary artery access for transcatheter aortic valve replacement (TAVR) at experienced medical centers in contemporary practice.

Background: There are no systematic comparisons of transcaval and transaxillary TAVR access routes.

Methods: Eight experienced centers contributed local data collected for the STS/ACC TVT Registry (Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry) between 2017 and 2020.

View Article and Find Full Text PDF
Article Synopsis
  • In a study of 318 high-risk atrial fibrillation patients who had left atrial appendage closure, researchers compared the safety and efficacy of direct oral anticoagulants (DOACs) to warfarin post-procedure.
  • The study found no significant difference in the rates of bleeding, thromboembolism, or cardiovascular death within 7 and 45 days between those discharged on DOACs and those on warfarin.
  • Overall, both medications showed similar patient outcomes, with low incidences of complications like major bleeding or device-related issues after the WATCHMAN procedure.
View Article and Find Full Text PDF

Current guidelines recommend 6-12 months of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) followed by aspirin monotherapy indefinitely. We aimed to assess the efficacy and safety of clopidogrel vs aspirin in the post-PCI population after completing DAPT. We systematically searched 5 electronic databases to identify studies comparing clopidogrel with aspirin following completion of DAPT after PCI.

View Article and Find Full Text PDF

Same-Day Discharge Post-Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic: The Multicenter PROTECT TAVR Study.

JACC Cardiovasc Interv

March 2022

Centre for Cardiovascular Innovation-Centre d'Innovation Cardiovasculaire, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

Objectives: The aim of this study was to determine the safety and efficacy of same-day discharge (SDD) after transcatheter aortic valve replacement (TAVR) during the COVID-19 pandemic.

Background: The COVID-19 pandemic has placed significant stress on health care systems worldwide. SDD in highly selected TAVR patients can facilitate the provision of essential cardiovascular care while managing competing COVID-19 resource demands.

View Article and Find Full Text PDF
Article Synopsis
  • A 51-year-old man with a history of diffuse lymphadenopathy presented with chest pain and a rash on his lower legs.
  • After undergoing various diagnostic tests including imaging, lab tests, and biopsy, he was diagnosed with rheumatoid vasculitis.
  • His condition was notably complicated by an unusual case of constrictive pericarditis.
View Article and Find Full Text PDF

In patient undergoing transcatheter aortic valve implantation (TAVI), stroke remains a potentially devastating complication associated with significant morbidity, and mortality. To reduce the risk of stroke, cerebral protection devices (CPD) were developed to prevent debris from embolizing to the brain during TAVI. We performed a systematic review and meta-analysis to determine the safety and efficacy of CPD in TAVI.

View Article and Find Full Text PDF

Contemporary data on gender differences in outcomes after transcatheter aortic valve implantation (TAVI), after stratification by age, remain limited. We studied age-stratified (60 to 70, 71 to 80, and 81 to 90 years) inhospital outcomes by gender after TAVI from the National Inpatient Sample database between 2012 and 2018. We analyzed National Inpatient Sample data using the International Classification of Diseases, Clinical Modification, Ninth Revision, and Tenth Revision claims codes.

View Article and Find Full Text PDF
Article Synopsis
  • Atrial arrhythmias frequently occur in patients with alcohol withdrawal syndrome (AWS) and lead to increased hospitalization rates.
  • A large-scale study analyzed data from over 1.5 million hospitalizations related to AWS, revealing that 9.72% of these patients had arrhythmias, which significantly impacted their health outcomes.
  • Patients with AWS and arrhythmias had higher in-hospital mortality, increased risks of complications (like heart failure and kidney injury), longer hospital stays, and greater treatment costs compared to those without arrhythmias.
View Article and Find Full Text PDF
Article Synopsis
  • The use of the Impella device in patients with ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS) has increased, despite limited evidence supporting its effectiveness from randomized trials.
  • A study analyzing 75,769 hospitalizations found that 10.75% received Impella support, while 34.70% received intra-aortic balloon pump (IABP) support; after adjustments, mortality was significantly higher for the Impella group (42.10% vs. 31.54%).
  • The results indicated that Impella is linked to greater in-hospital mortality and complications compared to IABP in STEMI patients with CS, suggesting IABP may be a more favorable option
View Article and Find Full Text PDF

Background: Due to the current Coronavirus Disease 2019 (COVID-19) pandemic, there is a realization for innovation in procedures and protocols to minimize hospital stay and at the same time ensure continued evidence-based treatment delivered to the patients. We present a same-day discharge protocol for transcatheter mitral valve repair (TMVR) using MitraClip under general anaesthesia in a six-patient case series. This protocol aims to reduce the length of hospital stay, thereby minimizing potential for nosocomial COVID-19 infections and to promote safe discharge with cautious follow-up.

View Article and Find Full Text PDF

Background: Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) and laceration of the anterior mitral leaflet to prevent outflow obstruction (LAMPOON) reduce the risk of coronary and left ventricular outflow obstruction obstruction during transcatheter aortic valve replacement and transcatheter mitral valve replacement. Despite successful laceration, BASILICA or LAMPOON may fail to prevent obstruction caused by inadequate leaflet splay in patients having challenging anatomy such as very small valve-to-coronary distance, diffusely calcified, rigid leaflets, or undergoing transcatheter aortic valve replacement inside existing transcatheter aortic valve replacement. We describe a novel technique of balloon-augmented (BA) leaflet laceration to enhance leaflet splay.

View Article and Find Full Text PDF

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study.

Circulation

October 2021

Li Ka Shing Knowledge Institute of St. Michael's Hospital, Institute of Medical Sciences and Departments of Anesthesia and Physiology, University of Toronto, ON, Canada (C.D.M.).

Background: Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated cell death that underlies AKI.

Methods: This prospective, multicenter, double-blind, randomized, controlled phase 2 trial evaluated the efficacy and safety of a single 10 mg/kg dose of teprasiran versus placebo (1:1), in reducing the incidence, severity, and duration of AKI after cardiac surgery in high-risk patients.

View Article and Find Full Text PDF
Article Synopsis
  • Contemporary data on stroke outcomes in patients undergoing transcatheter aortic valve implantation (TAVI) is limited, with 2.2% of the 215,938 patients studied suffering from stroke.
  • Stroke results in significantly higher adjusted mortality (10.9% vs 3.1%) and reduced likelihood of being discharged home (10.2% vs 52.3%) compared to those who did not have a stroke.
  • Key predictors for stroke include age, female sex, atrial fibrillation, chronic kidney disease, and peripheral vascular disease, with patients who suffered a stroke incurring higher costs ($63,367 vs $48,070) and longer hospital stays (8 days vs 4 days).
View Article and Find Full Text PDF

Background: Outcomes of patients with implanted left ventricular assist device (LVAD) implantation experiencing a cardiac arrest (CA) are not well reported. We aimed at defining the in-hospital outcomes of patients with implanted LVAD experiencing a CA.

Methods: The national inpatient sample (NIS) was queried using ICD9/ICD10 codes for patients older than 18 years with implanted LVAD and CA between 2010-2018.

View Article and Find Full Text PDF

Practical guidance to advisors of residents on the fellowship selection process.

J Community Hosp Intern Med Perspect

June 2021

Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, NY, USA.

Inability to Match into a fellowship is usually not a reflection of some failure on the part of the resident, but rather a problem of supply and demand. Understanding how to advise residents to maximize their success in an environment with limited spots and limited fellowship faculty resources to perform holistic review remains one of the primary objectives of most residency mentors. Residents can alter the odds in their favor by engaging with local faculty and in national society mentorship programs, performing 'enough' research, building their 'brand,' and concentrating on high quality personal statements.

View Article and Find Full Text PDF

Cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy: a case report.

Eur Heart J Case Rep

March 2021

Department of Advanced Heart Failure, Sands-Constellation Heart Institute, Rochester Regional Health, 1425 Portland Avenue, Rochester, NY 14621, USA.

Background: Cardiac sarcoidosis (CS) and arrhythmogenic right ventricular cardiomyopathy (ARVC) are rare causes of ventricular arrhythmias and are associated with sudden cardiac death. Differentiation between both is important for proper management.

Case Summary: We present a 56-year-old man with sudden cardiac arrest and was diagnosed to have ARVC based on cardiac magnetic resonance imaging (MRI).

View Article and Find Full Text PDF
Article Synopsis
  • Recurrent gastrointestinal bleeding (GIB) is a frequent issue for patients who have undergone left ventricular assist device (LVAD) implantation, prompting the need for effective prevention strategies.
  • This study conducted a network meta-analysis of 13 observational studies to compare the effectiveness of six different pharmacologic interventions aimed at preventing GIB.
  • The findings indicated that thalidomide, omega-3 fatty acids, octreotide, and danazol significantly reduced the risk of recurrent GIB, while ACE inhibitors/ARBs and digoxin showed no notable benefits.
View Article and Find Full Text PDF

Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry.

JACC Cardiovasc Interv

May 2021

Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

Objectives: This study sought to determine the safety of the BASILICA (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction) procedure.

Background: Transcatheter aortic valve replacement causes coronary artery obstruction in 0.7% of cases, with 40% to 50% mortality.

View Article and Find Full Text PDF

Introduction: The role of anticoagulation in octogenarians and nonagenarians with atrial fibrillation (AF) is controversial due to the lack of evidence from randomized controlled trials (RCTs), owing to the under representation of these patients in clinical trials.

Aim: In the present meta-analysis we aim at comparing the clinical benefits and risk of anticoagulation (AC) with no AC in octogenarians and nonagenarians.

Methods: We systematically searched MEDLINE/PubMed, EMBASE/Ovid, and Web of Science databases from the inception to October, 2020.

View Article and Find Full Text PDF

Transcatheter aortic valve replacement same-day discharge for selected patients: a case series.

Eur Heart J Case Rep

February 2021

Department of Cardiology, Sands Constellation Heart Institute, Rochester Regional Health, 1425 Portland Avenue, Rochester, NY 14621, USA.

Article Synopsis
  • - The COVID-19 pandemic forced healthcare systems to adapt, leading to a case series exploring same-day discharge (SDD) for patients undergoing transcatheter aortic valve replacement (TAVR) with remote cardiac monitoring.
  • - Six patients with severe aortic stenosis successfully had TAVR, were monitored for three hours, and discharged on the same day with remote monitoring if no complications arose.
  • - This approach potentially reduces COVID-19 exposure risks while ensuring safe recovery for selected patients following TAVR procedures.
View Article and Find Full Text PDF

Background: As the use of left atrial appendage closure (LAAC) becomes more widespread, improvements in resource utilization and cost-effectiveness are necessary. Currently, there are limited data on same-day discharge (SDD) after LAAC. We aimed to evaluate the safety and feasibility of SDD versus non-SDD in patients with nonvalvular atrial fibrillation who underwent LAAC.

View Article and Find Full Text PDF

Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis.

Am J Cardiol

March 2021

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address:

Article Synopsis
  • Cardiac amyloidosis (CA) is linked to a poor prognosis, particularly when patients have concurrent arrhythmias, which were found in 36.1% of hospital admissions over a two-year study period.
  • Patients with CA and arrhythmias experienced significantly higher all-cause mortality rates (13.9% vs. 5.3%) and increased instances of heart failure exacerbation compared to those without arrhythmias.
  • The hospitalization costs and length of stay were also notably greater for CA patients with arrhythmias, indicating a trend of worse outcomes and higher healthcare burdens in this group.
View Article and Find Full Text PDF